Phaseline

Companies › Tortugas Neuroscience

Tortugas Neuroscience: clinical trials, targets and expected readouts

2 active drug programs in 2 registered trials: 1 Phase 1, 1 Phase 2; Other; next expected readout Jan 2027.

Open in Phaseline: competitors, likelihood bands and readouts Company report

Programs

DrugTargetHighest phaseConditionsNext expected readout
TRTL-913–Phase 2TinnitusAug 2027
TRTL-729–Phase 1Healthy VolunteersJan 2027

Trials

Registry idDrugPhaseConditionsAreaExpected readout
NCT07811063TRTL-729Phase 1Healthy VolunteersOtherJan 2027
NCT07777549TRTL-913Phase 2TinnitusOtherAug 2027

Targets

No annotated target.

Companies with the same targets

–

Companies built like this

Sirnaomics Healx Skingenix Sensory Cloud Shanghai Huilun Pharmaceutical

Pipelines of the same shape: areas, drug types, target families, stage and cash runway.

Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.